Capital Advisors Ltd’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-302	Closed	-$7K	–	1400
2024 Q4	$7K	Hold	302	–	–	﹤0.01%	860
2024 Q3	$8K	Hold	302	–	–	﹤0.01%	818
2024 Q2	$7K	Buy	+302	New	+$7K	﹤0.01%	825